Mark Reinwald

2.1k citations

49 papers · 1.4k indexed · h-index 19

Impact in

Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Viral gastroenteritis research and epidemiology
Epidemiology top 5%
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment

Papers in

Infectious Diseases 30
- Antifungal resistance and susceptibility 26
Epidemiology 28
- Fungal Infections and Studies 24
- Pneumocystis jirovecii pneumonia detection and treatment 6

Co-authors: Dieter Buchheidt Birgit Spieß Wolf‐Karsten Hofmann Martin Hoenigl Tobias Boch Robert Krause Stefan Schwartz Juergen Prattes
Journals: Mycoses (5 papers)Blood (3 papers)BMC Infectious Diseases (2 papers)Annals of Hematology (2 papers)PLoS ONE (2 papers)
Partner nations: Germany United States Austria

In The Last Decade

Mark Reinwald

48 papers receiving 1.4k citations

Peers

Countries citing papers authored by Mark Reinwald

Since Specialization

Citations

This map shows the geographic impact of Mark Reinwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Reinwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Reinwald more than expected).

Fields of papers citing papers by Mark Reinwald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Reinwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Reinwald. The network helps show where Mark Reinwald may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Reinwald, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Reinwald Line = papers co-authored together Mark Reinwald links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays BMC Infectious Diseases ·J.J. Trujillo-Díaz, Mark Reinwald, Torsten Bauer, S D Gross, Jae Kyoung Lee, A. M. Antonova, Victor Herbst, Stefan Lüth, David J. Krieger, Werner Dammermann	2025	1
2	Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer BMC Cancer ·Christian Linke, Stéphanie Synard, Mark Reinwald, K. Koyama, René Mantke	2023	5
3	ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors) Clinical Microbiology and Infection ·Mark Reinwald, 潘光丁, Nicolas J. Mueller, Jesús Fortün, Christian Garzoni, Johan W. de Fijter, Mario Fernández‐Ruiz, Paolo Grossi, José María Aguado	2018	117
4	Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study Journal of Critical Care ·Tobias Boch, Mark Reinwald, Birgit Spieß, Tobias Liebregts, Peter Schellongowski, Patrick Meybohm, P.‐M. Rath, Jörg Steinmann, Frederik Trinkmann, S. Yetgin, R. Zimmerman-Bachman, Chadi Jabbour, W.‐K. Hofmann, Dieter Buchheidt	2018	45
5	Evaluating the use of PCR for diagnosing invasive aspergillosis Expert Review of Molecular Diagnostics ·Dieter Buchheidt, Mark Reinwald, Wolf‐Karsten Hofmann, Tobias Boch, Birgit Spieß	2017	13
6	Functional protease profiling for laboratory based diagnosis of invasive aspergillosis International Journal of Oncology ·Zulfa Sh. Badereddeen, Victor Costina, Dieter Buchheidt, Mark Reinwald, Michael Neumaier, Peter Findeisen	2015	4
7	Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test International Journal of Antimicrobial Agents ·Susanne Eigl, Juergen Prattes, Mark Reinwald, Christopher R. Thornton, Frederike Reischies, Birgit Spieß, Peter Neumeister, Ines Zollner‐Schwetz, Reinhard B. Raggam, Holger Flick, Dieter Buchheidt, Robert Krause, Martin Hoenigl	2015	67
8	Allogeneic hematopoietic cell transplantation without fluconazole and fluoroquinolone prophylaxis Annals of Hematology ·Daniela Heidenreich, Sebastian Kreil, Florian Nolte, Mark Reinwald, Wolf K. Hofmann, Stefan Klein	2015	12
9	Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients Critical Care ·Susanne Eigl, Juergen Prattes, Michaela Lackner, Birgit Willinger, Birgit Spieß, Mark Reinwald, Brigitte Selitsch, Michael Meilinger, Peter Neumeister, Frederike Reischies, Albert Wölfler, Reinhard B. Raggam, Holger Flick, Stephan Eschertzhuber, Robert Krause, Dieter Buchheidt, Christopher R. Thornton, Cornelia Lass‐Flörl, Martin Hoenigl	2015	66
10	Aspergillus Specific PCR and Galactomannan of Bronchoalveolar Lavage Are Superior to Concomitant Same-Day Testing of Concurrent Blood Samples in Immunocompromised Hematological Patients with Suspected Invasive Aspergillosis Blood ·Tobias Boch, Birgit Spieß, Oliver A. Cornely, Werner Heinz, J. Hahn, Stefan W. Krause, Hartmut Bertz, Wolf‐Karsten Hofmann, Dieter Buchheidt, Mark Reinwald	2015	1
11	The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience BMC Infectious Diseases ·FRANCOIS TROCHU, Margit Hummel, Joachim Brade, Edward J. McGoldrick, Wolf‐Karsten Hofmann, Dieter Buchheidt, Mark Reinwald	2014	8
12	Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013 PLoS ONE ·Birgit Spieß, Jenny Agnew, Mark Reinwald, Oliver A. Cornely, Axel Hamprecht, Martin Hoenigl, Cornelia Lass‐Flörl, Peter‐Michael Rath, Jörg Steinmann, Thomas Miethke, Melchior Lauten, Tetiana Kucher, Seong-hye Park, Wolf‐Karsten Hofmann, Dieter Buchheidt	2014	42
13	Prognostic importance of expression of the Wilms’ tumor 1 gene in newly diagnosed acute promyelocytic leukemia Leukemia & lymphoma ·Percy Fridenberg, Florian Nolte, Daniel Nowak, Verena Nowak, Mark Reinwald, Benjamin Hanfstein, Andreas Faldum, Thomas Büchner, Karsten Spiekermann, Cristina Sauerland, Christel Weiß, Wolf‐Karsten Hofmann, Eva Lengfelder	2014	8
14	Galactomannan-Based and PCR-Based Assays in Bronchoalveolar Lavage to Diagnose Invasive Aspergillosis: Current Status and Future Prospects Current Fungal Infection Reports ·Dieter Buchheidt, Birgit Spieß, Wolf‐Karsten Hofmann, Mark Reinwald	2013	2
15	Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies Journal of Antimicrobial Chemotherapy ·Mark Reinwald, Michael Hummel, Panwang Zhang, Birgit Spieß, Werner Heinz, Jörg Janne Vehreschild, Beate Schultheis, Stefan W. Krause, Claus Bachert, T. Suedhoff, Rainer Schwerdtfeger, Stefan Reuter, Michael Kiehl, W.‐K. Hofmann, Dieter Buchheidt	2012	80
16	In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival Leukemia Research ·Florian Nolte, Percy Fridenberg, Mark Reinwald, Daniel Nowak, Verena Nowak, Benjamin Hanfstein, Andreas Faldum, Thomas Büchner, Karsten Spiekermann, Cristina Sauerland, Wolf‐Karsten Hofmann, Eva Lengfelder	2012	10
17	Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors Journal of Neuro-Oncology ·Philipp Kiewe, Eckhard Thiel, Mark Reinwald, Agnieszka Korfel	2010	7
18	High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma Neuro-Oncology ·Philipp Kiewe, Christoph Loddenkemper, Ioannis Anagnostopoulos, Mark Reinwald, Eckhard Thiel, Agnieszka Korfel	2007	3
19	Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial Annals of Oncology ·Olaf Penack, Stefan Schwartz, Peter Martus, Mark Reinwald, Martin Schmidt‐Hieber, E. Thiel, IW Blau	2006	83
20	Quantitative real-time RT-PCR detects elevated Wilms tumor gene (WT1) expression in autologous blood stem cell preparations (PBSCs) from acute myeloid leukemia (AML) patients indicating contamination with leukemic blasts Bone Marrow Transplantation ·Guillermo Deloya Cobián, E. Thiel, 佐野弘弥, Mark Reinwald, Wolfgang Knauf, Jeffrey L. Webb	2002	13

About Mark Reinwald

Mark Reinwald is a scholar working on Infectious Diseases, Epidemiology, Hematology, Small Animals and Genetics, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (26 papers), Fungal Infections and Studies (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Acute Myeloid Leukemia Research (6 papers), Infectious Diseases and Mycology (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Plant Pathogens and Fungal Diseases (4 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Epidemiology (924 citations), Small Animals (165 citations), Cell Biology (154 citations) and Hematology (103 citations). Mark Reinwald has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Dieter Buchheidt, Birgit Spieß, Wolf‐Karsten Hofmann, Martin Hoenigl, Tobias Boch, Robert Krause, Stefan Schwartz, Juergen Prattes, Martin Schmidt‐Hieber and Eckhard Thiel. Their work appears in journals such as Mycoses, Blood, BMC Infectious Diseases, Annals of Hematology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact